Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels.
Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases.
Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.
Industry
Biotechnology, Scientific Research and Development Services, Services
HQ Location
1700 Owens Street, Suite 205
San Francisco, CA 94158, US
Keywords
researchlife sciencesbiotechnologypharmaceutical chemistrytransfusion medicinestrategy consultingmedical advisorystrategy and developmentcell cyclechemistry and biochemistry